FibroGen, Inc.Ā (NASDAQ: FGEN) Q4 2021 earnings call dated Feb. 28, 2022 Corporate Participants: Michael TungĀ —Ā Vice President, Corporate Strategy &...
ImmunoGen, Inc.Ā (NASDAQ: IMGN) FY 2021 earnings call dated Feb. 25, 2022 Corporate Participants: Courtney O’KonekĀ —Ā Senior Director of Corporate Communications...
Moderna, Inc.Ā (NASDAQ: MRNA) Q4 2021 earnings call dated Feb. 24, 2022 Corporate Participants: Lavina TalukdarĀ —Ā Senior Vice President & Head of...
Sage Therapeutics, Inc.Ā (NASDAQ: SAGE) Q4 2021 earnings call dated Feb. 24, 2022 Corporate Participants: Helen RubinsteinĀ —Ā Investor Relations Officer Barry...
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q4 2021 earnings call dated Feb. 15, 2022 Corporate Participants: Atabak MokariĀ —Ā Chief Financial Officer Charles...
The biomedical industry grew at an accelerated pace in 2021 even as healthcare systems went into overdrive amidst the COVID-induced...
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q4 2021 earnings call dated Feb. 04, 2022 Corporate Participants: Mark HudsonĀ —Ā Director, Investor Relations Leonard...
Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than expected earnings and revenues for the fourth quarter. The...
Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2021 earnings results today. Total revenue decreased 4% year-over-year to $2.73 billion. GAAP...
The IPO market is recovering from the slowdown experienced towards the end of 2021, with pharma companies dominating the scene...
Vertex Pharmaceuticals IncorporatedĀ (NASDAQ: VRTX) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Michael PartridgeĀ —Ā Senior Vice President of...
Evelo Biosciences (Nasdaq:EVLO) is a clinical-stage biotechnology company that is focused on a newly uncovered area of central human biology...
The pharma sector has been on a stable growth trajectory lately, and the trend gathered momentum when the pandemic-related emergency...
Tell us a bit about your clinical programs and how they are different from the existing therapies. Addex is a...
What is Equillium all about? We started the company four years ago around our lead drug program itolizumab. My colleague,...
Avid Bioservices, Inc. (NASDAQ: CDMO) Q2 2022 earnings call dated Dec. 07, 2021 Corporate Participants: Tim BronsĀ —Ā Investor Relations, Vida Strategic...
After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed...
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) Q4 2021 earnings call, dated Nov. 22, 2021. Corporate Participants: Vince AnzaloneĀ —Ā Vice President of Investor...
Cara Therapeutics, Inc. (NASDAQ: CARA) Q3 2021 earnings call dated Nov. 08, 2021 Corporate Participants: Will Gramig — Senior Analyst Derek Chalmers — Chief...
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q3 2021 earnings call dated Nov. 03, 2021 Corporate Participants: Atabak MokariĀ —Ā Chief Financial Officer Charles...
